新诺威：为促进成药业务发展，筹划发行H股并在香港联交所主板上市

Core Viewpoint - The company is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy and competitiveness in the international market [1] Group 1: Company Actions - The company held the 26th meeting of the 6th Board of Directors and the 21st meeting of the 6th Supervisory Board to approve the proposal for the issuance of H-shares [1] - The company is currently in discussions with relevant intermediaries regarding the issuance and listing of H-shares [1] Group 2: Strategic Goals - The issuance of H-shares aims to deepen the company's global strategic layout and create an international capital operation platform [1] - The initiative is expected to promote the development of the company's pharmaceutical business [1]